Skip to content

Integra LifeSciences IART Book value per share

Book value per share at other companies

Axogen logo
AxogenAXGN
$4.75+104%
Globus Medical logo
Globus MedicalGMED
$34.24+17.1%
AbbVie logo
AbbVieABBV
-$3.75-568%
Medtronic logo
MedtronicMDT
$38.40+3.1%
ITG
Integer HoldingsITGR
$49.28+4.0%
Merit Medical Systems logo
Merit Medical SystemsMMSI
$27.11+16.3%

Other financials

Income statement

See full
Revenue$391.9M+2.4%
Gross profit$217.0M+11.6%
Operating income$11.5M+174%
Net income-$4.6M+81.7%
EPS (diluted)-$0.06+81.8%

Balance sheet

See full
Cash & equivalents$236.8M-1.0%
Total debt$2.0B+3.2%
Total equity$1.0B-31.6%
Total assets$3.6B-11.7%

Cash flow

See full
Operating cash flow$9.8M+187%
CapEx$14.8M-48.7%
Free cash flow-$5.0M+87.4%

Valuation

See full
Market cap$1.38B+53.4%
Enterprise value$3.12B+21.1%
P/S0.8×+0.3×

Profitability

See full
Gross margin51.9%-1.6pp
Operating margin-29.8%-30.3pp
Net margin-30.1%
FCF margin3.8%-6.3pp

Returns & leverage

See full
Return on equity-38.6%
Debt / equity1.9×+0.6×
Current ratio3.4×+2.2×

Where this comes from

Calculated from Integra LifeSciences’s reported figures.

Based on the most recent quarter.

The official record: Integra LifeSciences’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Integra LifeSciences's book value per share.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Integra LifeSciences's book value per share?
Integra LifeSciences (IART) reported book value per share of $13.55 in Q1 2026.
How has Integra LifeSciences's book value per share changed year-over-year?
Integra LifeSciences's book value per share decreased by 32.0% year-over-year, from $19.93 to $13.55.
What is the long-term trend for Integra LifeSciences's book value per share?
Over 5 years (2020 to 2025), Integra LifeSciences's book value per share has grown at a -5.2% compound annual growth rate (CAGR), from $17.77 to $13.61.
What does book value per share mean?
Shareholders' equity divided by diluted shares outstanding at the quarter end. The accounting (book) value attributable to each share.